Petushkova E V, Kodentsova V M
Biokhimiia. 1982 Mar;47(3):434-41.
The effects of several phosphorylating and alkylating analogs of the substrate on the ATPase activity of myosin and heavy meromyosin were compared. The data obtained confirmed the previously made assumption on the existence of two types of substrate-like inhibitor binding sites in the enzyme molecule. In one of the sites, presumably in the active one, there occurs a reversible competitive inhibition characterized by a high affinity for the inhibitors, which are mixed anhydrides of various mononucleotides and mesitylcarboxylic acid or its derivatives. An enhancement of hydrophobicity of these compounds causes an increase in their affinity for this site. At much higher concentrations of the inhibitors an irreversible inhibition takes place, the rate of inhibition being decreased with an increase in the phosphorylating capacity of the compound. This site possesses a far lower affinity for the inhibitors and reveals a certain specificity with respect to the analog mononucleotide moiety structure, i.e. a replacement of the 6-NH2-group by the 6-OH-group or an increase in the number of the phosphate residues result in a decrease of the efficiency of inhibition. No correlation between the analog capacity to cause irreversible inhibition and to act as an effective competitive inhibitor of reversible type has been shown to exist, thus allowing to use inhibitors of preferable action in one of the two types of the binding sites. No irreversible inhibition site was revealed when the ATPase activity of myosin subfragment I with and without the DTNB chains was investigated. Actin protects myosin against the inhibiting action of the analogs tested.
比较了底物的几种磷酸化和烷基化类似物对肌球蛋白和重酶解肌球蛋白ATP酶活性的影响。所获得的数据证实了先前关于酶分子中存在两种底物样抑制剂结合位点的假设。在其中一个位点,大概是活性位点,发生可逆竞争性抑制,其特征是对抑制剂具有高亲和力,这些抑制剂是各种单核苷酸与均三甲苯羧酸或其衍生物的混合酸酐。这些化合物疏水性的增强导致它们对该位点的亲和力增加。在高得多的抑制剂浓度下会发生不可逆抑制,抑制速率随化合物磷酸化能力的增加而降低。该位点对抑制剂的亲和力低得多,并且对类似单核苷酸部分结构表现出一定的特异性,即6-NH2基团被6-OH基团取代或磷酸残基数增加会导致抑制效率降低。尚未显示出类似物引起不可逆抑制的能力与作为可逆类型有效竞争性抑制剂的作用之间存在相关性,因此可以在两种结合位点之一中使用具有优选作用的抑制剂。在研究有和没有DTNB链的肌球蛋白亚片段I的ATP酶活性时,未发现不可逆抑制位点。肌动蛋白可保护肌球蛋白免受所测试类似物的抑制作用。